David Pelizzon Biography and Net Worth

Director of OrthoPediatrics

David Pelizzon is a retired US Army officer who served almost 30 years on active duty in airborne and special operations units. Since his retirement from active duty in 2003, he has worked as a manufacturing executive in the US and Asia. Prior to starting Squadron Capital Mr. Pelizzon was the Managing Director of Precision Edge Holdings, Colson Associates in Chicago. Currently he is the President of Squadron Capital, a firm that primarily manages direct investments in operating companies and that also invests in private equity funds and special situations in support of the long term investment objectives of a Chicago based trust. Mr. Pelizzon is a graduate of the US Military Academy and has advanced degrees from Harvard University and the US Naval War College.

What is David R. Pelizzon's net worth?: The estimated net worth of David R. Pelizzon is at least $164.93 million as of August 26th, 2026. Mr. Pelizzon owns 6,863,464 shares of OrthoPediatrics stock worth more than $164,929,040 as of August 27th. This net worth approximation does not reflect any other assets that Mr. Pelizzon may own. Learn More about David R. Pelizzon's net worth.
How do I contact David R. Pelizzon?: The corporate mailing address for Mr. Pelizzon and other OrthoPediatrics executives is 2850 Frontier Drive, Warsaw IN, 46582. OrthoPediatrics can also be reached via phone at (574) 268-6379 and via email at [email protected]. Learn More on David R. Pelizzon's contact information.
Has David R. Pelizzon been buying or selling shares of OrthoPediatrics?: Within the last three months, David R. Pelizzon has sold $943,302.00 of OrthoPediatrics stock. Most recently, David R. Pelizzon sold 18,000 shares of the business's stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $24.28, for a transaction totalling $437,040.00. Following the completion of the sale, the director now directly owns 6,863,464 shares of the company's stock, valued at $166,644,905.92. Learn More on David R. Pelizzon's trading history.
Who are OrthoPediatrics' active insiders?: OrthoPediatrics' insider roster includes David Bailey (President & CEO), Bernei Berry, III (Director), Stephen Burns (Director), Daniel Gerritzen (Executive Vice President (Legal) & General Counsel), Joseph Hauser (President of Trauma and Deformity Correction), Fred Hite (CFO), Marie Infante (Director), Gregory Odle (EVP), David Pelizzon (Director), Jennifer Pritzker (Major Shareholder), Terry Schlotterback (Director), and Mark Throdahl (CEO). Learn More on OrthoPediatrics' active insiders.
Are insiders buying or selling shares of OrthoPediatrics?: In the last twelve months, insiders at the sold shares 14 times. They sold a total of 173,071 shares worth more than $3,833,355.75. The most recent insider tranaction occured on August, 26th when Major Shareholder Jennifer N Pritzker sold 18,000 shares worth more than $437,040.00. Insiders at OrthoPediatrics own 32.5% of the company. Learn More about insider trades at OrthoPediatrics.
Information on this page was last updated on 8/26/2026.

David R. Pelizzon Insider Trading History at OrthoPediatrics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/26/2026	Sell	18,000	$24.28	$437,040.00	6,863,464
8/25/2026	Sell	16,300	$24.74	$403,262.00	6,881,464
8/24/2026	Sell	4,000	$25.75	$103,000.00	6,897,764
3/15/2021	Buy	3,700	$46.50	$172,050.00	20,900
5/22/2018	Buy	2,000	$19.50	$39,000.00
3/12/2018	Buy	1,000	$17.50	$17,500.00

David R. Pelizzon Buying and Selling Activity at OrthoPediatrics

OrthoPediatrics Company Overview

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Today's Range

Now: $23.72

$24.00

$24.91

50 Day Range

MA: $21.23

$18.16

$26.50

2 Week Range

Now: $23.72

$14.42

$26.74

Volume

169,608 shs

Average Volume

266,150 shs

Market Capitalization

$619.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98